Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ATYPICAL ANTIPSYCHOTICS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 142 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Felice Vadruccio; Giovanni Biricolti; Leonardo Mendolicchio
      Analisi farmacoeconomica del trattamento di pazienti psicotici cronici con olanzapina, antipsicotici atipici e neurolettici tipici: uno studio regionale

      Farmeconomia e percorsi terapeutici
    2. Fear, C
      Managing schizophrenia: an update

      HOSPITAL MEDICINE
    3. Ghaemi, SN
      On defining 'mood stabilizer'

      BIPOLAR DISORDERS
    4. Strakowski, SM; DelBello, MP; Adler, CM
      Comparative efficacy and tolerability of drug treatments for bipolar disorder

      CNS DRUGS
    5. Onrust, SV; McClellan, K
      Perospirone

      CNS DRUGS
    6. Osser, DN; Sigadel, R
      Short-term inpatient pharmacotherapy of schizophrenia

      HARVARD REVIEW OF PSYCHIATRY
    7. Edell, WS; Tunis, SL
      Antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychiatric inpatients

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    8. Robinet, EA; Wurch, T; Pauwels, PJ
      Different regulation of RGS2 mRNA by haloperidol and clozapine

      NEUROREPORT
    9. Aleman, A; Kahn, RS
      Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    10. Kane, JM
      Extrapyramidal side effects are unacceptable

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    11. Lesage, AD; Stip, E; Grunberg, F
      What's up, doc? Context, limitations, and issues for clinicians in evidence-based medicine

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    12. McIntyre, RS; McCann, SM; Kennedy, SH
      Antipsychotic metabolic effects: Weight gain, diabetes mellitus, and lipidabnormalities

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    13. Bolos, J; Princep, M; Guglietta, A
      Abaperidone hydrochloride. Antipsychotic, dopamine D-2 antagonist, 5-HT2A antagonist

      DRUGS OF THE FUTURE
    14. Sa, DS; Kapur, S; Lang, AE
      Amoxapine shows an antipsychotic effect but worsens motor function in patients with Parkinson's disease and psychosis

      CLINICAL NEUROPHARMACOLOGY
    15. Esel, E; Basturk, M; Gonul, AS; Kula, M; Turan, MT; Yabanoglu, I; Sofuoglu, S
      Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients

      PSYCHONEUROENDOCRINOLOGY
    16. Lecrubier, Y; Azorin, M; Bottai, T; Dalery, J; Garreau, G; Lemperiere, T; Lisoprawski, A; Petitjean, F; Vanelle, JM
      Consensus on the practical use of amisulpride, an atypical antipsychotic, in the treatment of schizophrenia

      NEUROPSYCHOBIOLOGY
    17. Remington, G; Khramov, I
      Health care utilization in patients with schizophrenia maintained on atypical versus conventional antipsychotics

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    18. Wilton, LV; Heeley, EL; Pickering, RM; Shakir, SA
      Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine

      JOURNAL OF PSYCHOPHARMACOLOGY
    19. Kasper, S; Rosillon, D; Duchesne, I
      Risperidone Olanzapine Drug Outcomes studies in Schizophrenia (RODOS): efficacy and tolerability results of an international naturalistic study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    20. Kasper, S; Jones, M; Duchesne, I
      Risperidone Olanzapine Drug Outcomes studies in Schizophrenia (RODOS): health economic results of an international naturalistic study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    21. Barbui, C; Campomori, A; Mezzalira, L; Lopatriello, S; Da Cas, R; Garattini, S
      Psychotropic drug use in Italy, 1984-99: the impact of a change in reimbursement status

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    22. Kasper, S; Quiner, S; Barnas, C; Fabisch, T; Haushofer, M; Sackel, C; Konig, P; Lingg, A; Platz, T; Rittmannsberger, H; Stuppack, C; Willeit, M; Zapotoczky, HG
      Zotepine in the treatment of acute hospitalized schizophrenic episodes

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    23. Kodesh, A; Finkel, B; Lerner, AG; Kretzmer, G; Sigal, M
      Dose-dependent olanzapine-associated leukopenia: three case reports

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    24. Garcia-Anaya, M; Apiquian, R; Fresan, A
      Atypical anti-psychotics: review article.

      SALUD MENTAL
    25. Fontaine, KR; Heo, M; Harrigan, EP; Shear, CL; Lakshminarayanan, M; Casey, DE; Allison, DB
      Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate

      PSYCHIATRY RESEARCH
    26. Davis, JM; Chen, N
      The effects of olanzapine on the 5 dimensions of schizophrenia derived by factor analysis: Combined results of the North American and international trials

      JOURNAL OF CLINICAL PSYCHIATRY
    27. Allison, DB; Casey, DE
      Antipsychotic-induced weight gain: A review of the literature

      JOURNAL OF CLINICAL PSYCHIATRY
    28. Alves, CRR; Silva, MTA
      Facilitation of latent inhibition by the atypical antipsychotic risperidone

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    29. Parnetti, L; Amici, S; Lanari, A; Gallai, V
      Pharmacological treatment of non-cognitive disturbances in dementia disorders

      MECHANISMS OF AGEING AND DEVELOPMENT
    30. Rojas, P; Arancibia, P; Bravo, V; Varela, S
      Diabetes mellitus associated with olanzapine use

      REVISTA MEDICA DE CHILE
    31. Glick, ID; Murray, SR; Vasudevan, P; Marder, SR; Hu, RJ
      Treatment with atypical antipsychotics: new indications and new populations

      JOURNAL OF PSYCHIATRIC RESEARCH
    32. Guiso, G; Caccia, S
      Distribution of the methylpiperazinopyridobenzoxazepine derivative JL13, apotential antipsychotic, in rat brain

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    33. Lopez-Gimenez, JF; Vilaro, MT; Palacios, JM; Mengod, G
      Mapping of 5-HT2A receptors and their mRNA in monkey brain: [H-3]MDL100,907 autoradiography and in situ hybridization studies

      JOURNAL OF COMPARATIVE NEUROLOGY
    34. Curran, MP; Perry, CM
      Amisulpride - A review of its use in the management of schizophrenia

      DRUGS
    35. Dawe, GS; Huff, KD; Vandergriff, JL; Sharp, T; O'Neill, MJ; Rasmussen, K
      Olanzapine activates the rat locus coeruleus: In vivo electrophysiology and c-fos immunoreactivity

      BIOLOGICAL PSYCHIATRY
    36. Bertolino, A; Callicott, JH; Mattay, VS; Weidenhammer, KM; Rakow, R; Egan, MF; Weinberger, DR
      The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia

      BIOLOGICAL PSYCHIATRY
    37. Woods, SW; Stolar, M; Sernyak, MJ; Charney, DS
      Consistency of atypical antipsychotic superiority to placebo in recent clinical trials

      BIOLOGICAL PSYCHIATRY
    38. Kruse, D; Pantelis, C; Rudd, R; Quek, J; Herbert, P; McKinley, M
      Treatment of psychogenic polydipsia: comparison of risperidone and olanzapine, and the effects of an adjunctive angiotensin-II receptor blocking drug(irbesartan)

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
    39. Hubl, D; Kleinlogel, H; Frohlich, L; Weinandi, T; Maurer, K; Holstein, W; Czekalla, J; Dierks, T
      Multilead quantitative electroencephalogram profile and cognitive evoked potentials (P300) in healthy subjects after a single dose of olanzapine

      PSYCHOPHARMACOLOGY
    40. Wahlbeck, K; Tuunainen, A; Ahokas, A; Leucht, S
      Dropout rates in randomised antipsychotic drug trials

      PSYCHOPHARMACOLOGY
    41. Heresco-Levy, U
      N-methyl-D-aspartate (NMDA) receptor-based treatment approaches in schizophrenia: the first decade

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    42. Brecher, M; Rak, IW; Melvin, K; Jones, AM
      The long-term effect of quetiapine (Seroquel (TM)) monotherapy on weight in patients with schizophrenia

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    43. Reznik, I; Benatov, R; Sirota, P
      Long-term efficacy and safety of quetiapine in treatment-refractory schizophrenia: A case report

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    44. Jain, KK
      An assessment of iloperidone for the treatment of schizophrenia

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    45. Matheson, AJ; Lamb, HM
      Quetiapine - A review of its clinical potential in the management of psychotic symptoms in Parkinson's disease

      CNS DRUGS
    46. Bhana, N; Spencer, CM
      Risperidone - A review of its use in the management of the behavioural andpsychological symptoms of dementia

      DRUGS & AGING
    47. Bettinger, TL; Mendelson, SC; Dorson, PG; Crismon, ML
      Olanzapine-induced glucose dysregulation

      ANNALS OF PHARMACOTHERAPY
    48. McDougle, CJ; Scahill, L; McCracken, JT; Aman, MG; Tierney, E; Arnold, LE; Freeman, BJ; Martin, A; McGough, JJ; Cronin, P; Posey, DJ; Riddle, MA; Ritz, L; Swiezy, NB; Vitiello, B; Volkmar, FR; Votolato, NA; Walson, P
      Research Units on Pediatric Psychopharmacology (RUPP) autism network - Background and rationale for an initial controlled study of risperidone

      CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA
    49. DelBello, MP; Foster, KD; Strakowski, SM
      Case report: Treatment of catatonia in an adolescent male

      JOURNAL OF ADOLESCENT HEALTH
    50. Brene, S; Messer, C; Okado, H; Hartley, M; Heinemann, SF; Nestler, EJ
      Regulation of GluR2 promoter activity by neurotrophic factors via a neuron-restrictive silencer element

      EUROPEAN JOURNAL OF NEUROSCIENCE
    51. Combs, DR; Advokat, C
      Antipsychotic medication and smoking prevalence in acutely hospitalized patients with chronic schizophrenia

      SCHIZOPHRENIA RESEARCH
    52. Ohashi, K; Hamamura, T; Lee, Y; Fujiwara, Y; Suzuki, H; Kuroda, S
      Clozapine- and olanzapine-induced Fos expression in the rat medial prefrontal cortex is mediated by beta-adrenoceptors

      NEUROPSYCHOPHARMACOLOGY
    53. Svingos, AL; Periasamy, S; Pickel, VM
      Presynaptic dopamine D-4 receptor localization in the rat nucleus accumbens shell

      SYNAPSE
    54. Kulkarni, SK; Ninan, I
      Dopamine D-4 receptors and development of newer antipsychotic drugs

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    55. Caccia, S
      Biotransformation of post-clozapine antipsychotics - Pharmacological implications

      CLINICAL PHARMACOKINETICS
    56. Beaumont, G
      Antipsychotics - The future of schizophrenia treatment

      CURRENT MEDICAL RESEARCH AND OPINION
    57. Bruggeman, R; Heeringa, M; Westerink, BHC; Timmerman, W
      Combined 5-HT2/D-2 receptor blockade inhibits the firing rate of SNR neurons in the rat brain

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    58. Taylor, DM; Duncan-McConnell, D
      Refractory schizophrenia and atypical antipsychotics

      JOURNAL OF PSYCHOPHARMACOLOGY
    59. Soares, JC
      Recent advances in the treatment of bipolar mania, depression, mixed states, and rapid cycling

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    60. Pezawas, L; Quiner, S; Moertl, D; Tauscher, J; Barnas, C; Kufferle, B; Wolf, R; Kasper, S
      Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    61. Barzega, G; Bogetto, F; Maina, G; Ravizza, L
      Quetiapine in schizophrenic patients: A high- and low-dose double-blind comparison

      EUROPEAN JOURNAL OF PSYCHIATRY
    62. Ciapparelli, A; Dell'Osso, L; Pini, S; Chiavacci, MC; Fenzi, M; Cassano, GB
      Clozapine for treatment-refractory schizophrenia, schizoaffective disorderand psychotic bipolar disorder: A 24-month naturalistic study

      JOURNAL OF CLINICAL PSYCHIATRY
    63. Turnheim, K
      Adverse effects of psychotropic drugs in the elderly

      WIENER KLINISCHE WOCHENSCHRIFT
    64. Hilger, E; Kasper, S
      Properties and therapeutic use of atypical antipsychotics: a review

      WIENER KLINISCHE WOCHENSCHRIFT
    65. Frohlich, PF; Meston, CM
      Evidence that serotonin affects female sexual functioning via peripheral mechanisms

      PHYSIOLOGY & BEHAVIOR
    66. Keltner, NL; Coffeen, H; Johnson, JE
      Atypical antipsychotic drugs: Part 1

      PERSPECTIVES IN PSYCHIATRIC CARE
    67. Michel, FJ; Trudeau, LE
      Clozapine inhibits synaptic transmission at GABAergic synapses establishedby ventral tegmental area neurones in culture

      NEUROPHARMACOLOGY
    68. Lambert, M; Moritz, S; Haasen, C; Naber, D
      Conversion from conventional to atypical neuroleptics - recommendations for inpatient and outpatient treatment

      NERVENARZT
    69. Jatzko, A; Ries, S; Schreiner, A; Braus, DF
      Acute tongue and pharyngeal cramps when changing from clozapine to amisupride. A case study

      NERVENARZT
    70. Rowley, HL; Needham, PL; Kilpatrick, IC; Heal, DJ
      A comparison of the acute effects of zotepine and other antipsychotics on rat cortical dopamine release, in vivo

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    71. Ravina, E; Casariego, I; Masaguer, CF; Fontenla, JA; Montenegro, GY; Rivas, ME; Loza, MI; Enguix, MJ; Villazon, M; Cadavid, MI; Demontis, GC
      Conformationally constrained butyrophenones with affinity for dopamine (D-1, D-2, D-4) and serotonin (5-HT2A, 5-HT2B, 5-HT2c) receptors: Synthesis ofaminomethylbenzo[b]furanones and their evaluation as antipsychotics

      JOURNAL OF MEDICINAL CHEMISTRY
    72. Bolos, J; Loscertales, T; Nieto, J; Sacristan, A; Ortiz, JA
      A new efficient synthesis of 3-(hydroxymethyl)-4H-chromen-4-ones

      JOURNAL OF HETEROCYCLIC CHEMISTRY
    73. McElroy, SL; Keck, PE
      Pharmacologic agents for the treatment of acute bipolar mania

      BIOLOGICAL PSYCHIATRY
    74. Wadenberg, MLG; Sills, TL; Fletcher, PJ; Kapur, S
      Antipsychoticlike effects of amoxapine, without catalepsy, using the prepulse inhibition of the acoustic startle reflex test in rats

      BIOLOGICAL PSYCHIATRY
    75. Silvestri, S; Seaman, MV; Negrete, JC; Houle, S; Shammi, CM; Remington, GJ; Kapur, S; Zipursky, RB; Wilson, AA; Christensen, BK; Seeman, P
      Increased dopamine D-2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study

      PSYCHOPHARMACOLOGY
    76. Aman, MG; Madrid, A
      Atypical antipsychotics in persons with developmental disabilities

      MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS
    77. Brown, CS; Markowitz, JS; Moore, TR; Parker, NG
      Atypical antipsychotics: Part II - Adverse effects, drug interactions, andcosts

      ANNALS OF PHARMACOTHERAPY
    78. Markowitz, JS; Brown, CS; Moore, TR
      Atypical antipsychotics - Part I: Pharmacology, pharmacokinetics, and efficacy

      ANNALS OF PHARMACOTHERAPY
    79. Homan, EJ; Copinga, S; Unelius, L; Jackson, DM; Wikstrom, HV; Grol, CJ
      Synthesis and pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT

      BIOORGANIC & MEDICINAL CHEMISTRY
    80. Lopez-Gimenez, JF; Mengod, G; Palacios, JM; Vilaro, MT
      Human striosomes are enriched in 5-HT2A receptors: autoradiographical visualization with [H-3]MDL100,907, [I-125](+/-)DOI and [H-3]ketanserin

      EUROPEAN JOURNAL OF NEUROSCIENCE
    81. Altamura, AC; Boin, F; Maes, M
      HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    82. Keck, PE; McElroy, SL; Strakowski, SM
      Schizoaffective disorder: role of atypical antipsychotics

      SCHIZOPHRENIA RESEARCH
    83. Casey, DE
      Tardive dyskinesia and atypical antipsychotic drugs

      SCHIZOPHRENIA RESEARCH
    84. Ninan, I; Kulkarni, SK
      Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    85. Green, B
      Focus on quetiapine

      CURRENT MEDICAL RESEARCH AND OPINION
    86. Advokat, CD; Bertman, LJ; Comaty, JE
      Clinical outcome to clozapine treatment in chronic psychiatric inpatients

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    87. Porter, JH; Villanueva, HF; Rosecrans, JA
      Role of D-1 and D-2 dopamine receptors in the discriminative stimulus properties of the atypical antipsychotic clozapine in rats

      DRUG DEVELOPMENT RESEARCH
    88. Simon, AE; Aubry, JM; Malky, L; Bertschy, G
      Hypomania-like syndrome induced by olanzapine

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    89. Pallanti, S; Quercioli, L; Pazzagli, A
      Effects of clozapine on awareness of illness and cognition in schizophrenia

      PSYCHIATRY RESEARCH
    90. Smith, JA; Boyer-Millar, C; Goudie, AJ
      Does MK-801 discrimination constitute an animal model of schizophrenia useful for detecting atypical antipsychotics?

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    91. Williams, CL; Johnstone, BM; Kesterson, JG; Javor, KA; Schmetzer, AD
      Evaluation of antipsychotic and concomitant medication use patterns in patients with schizophrenia

      MEDICAL CARE
    92. Srinivas, P; Subramanian, AR; Brust, P; Raghavan, SAV; Rangisetty, JB; Gupta, CNVHB; Sridhar, N; Veeranjaneyulu, A; Parimoo, P
      Synthesis and preliminary pharmacological investigations of 1-(1,2-dihydro-2-acenaphthylenyl)piperazine derivatives as potential atypical antipsychotic agents in mice

      FARMACO
    93. Shen, WW
      A history of antipsychotic drug development

      COMPREHENSIVE PSYCHIATRY
    94. Kapur, S; Cho, R; Jones, C; McKay, G; Zipursky, RB
      Is amoxapine an atypical antipsychotic? Positron-emission tomography investigation of its dopamine(2) and serotonin(2) occupancy

      BIOLOGICAL PSYCHIATRY
    95. Homan, EJ; Copinga, S; Elfstrom, L; van der Veen, T; Hallema, JP; Mohell, N; Unelius, L; Johansson, R; Wikstrom, HV; Grol, CJ
      2-aminotetralin-derived substituted benzamides with mixed dopamine D-2, D-3, and serotonin 5-HT1A receptor binding properties: A novel class of potential atypical antipsychotic agents

      BIOORGANIC & MEDICINAL CHEMISTRY
    96. SOSKIC V; JOKSIMOVIC J
      BIOISOSTERIC APPROACH IN THE DESIGN OF NEW DOPAMINERGIC SEROTONERGIC LIGANDS/

      Current medicinal chemistry
    97. KING DJ
      DRUG-TREATMENT OF THE NEGATIVE SYMPTOMS OF SCHIZOPHRENIA

      European neuropsychopharmacology
    98. KNAPP MRJ
      MEASURING THE ECONOMIC BENEFIT OF TREATMENT WITH ATYPICAL ANTIPSYCHOTICS

      European psychiatry
    99. GERACIOTI TD; PARKER S; LOWTHER NB; WORTMAN M; RICHTAND NM
      A CASE OF TREATMENT-REFRACTORY PSYCHOSIS RESPONSIVE TO SERTINDOLE

      Schizophrenia research
    100. TEEHAN M
      ISSUES OF CHOICE IN 2ND-GENERATION ANTIPSYCHOTIC AGENTS

      Canadian journal of psychiatry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/19 alle ore 05:03:10